LPL and metabolic syndrome: Fibrates are used especially in hypertriglyceridemia and mixed dyslipidemia, acting as agonists on peroxisome proliferator-activated receptor-alpha (PPAR-alpha) which leads to the activation of lipoprotein lipase with the subsequent degradation of VLDL fraction rich in triglycerides.